Viewing Study NCT00144495


Ignite Creation Date: 2025-12-24 @ 1:31 PM
Ignite Modification Date: 2025-12-25 @ 12:33 PM
Study NCT ID: NCT00144495
Status: COMPLETED
Last Update Posted: 2009-02-02
First Post: 2005-09-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy
Sponsor: Chugai Pharmaceutical
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: EPO308JP
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Chugai Pharmaceutical
Old Organization: Chugai Pharmaceutical

Collaborators